LEGAL FRAMEWORk GOVERNING THE TYPES AND HANDLING OF MEDICINAL PRODUCTS WITH AN OVERVIEW OF PRINCIPLES OF GOOD PHARMACY IN THE PROVISION OF PHARMACEUTICAL SERVICES IN SERBIA

Jovana Cicmil

doi:10.51738/kpolisa.2026.1r.jc

Authors

Jovana Cicmil University Business Academy, Novi Sad, Serbia Faculty of Pharmacy https://orcid.org/0000-0003-0254-3685

DOI:

https://doi.org/10.51738/kpolisa.2026.1r.jc

Keywords:

medicinal product, medical device, pharmaceutical activity, Good Pharmacy Practice, healthcare

Abstract

The healthcare system represents one of the most complex systems in any state. Article 65 of the Law on Health Care stipulates that pharmaceutical healthcare is included among the activities constituting healthcare provision at the primary level. At the national level, each country establishes a positive legal framework governing the field related to the types and handling of medicinal products, as we l as other key issues, primarily through the adoption of relevant laws and bylaws. It is generally considered that any pharmacotherapy necessarily implies a coherent approach among all participants in the process — patients, physicians, pharmacists, and other professionals whose medical services may be required. Following a brief overview of the concept and significance of pharmaceutical activity, medicinal products, and medical devices, this paper analyzes the legal framework regulating the types and handling of medicinal products. In addition to examining the applicable laws, relevant bylaws are also presented. Finally, the paper provides an overview of the principles of Good Pharmacy Practice in the provision of pharmaceutical services in Serbia.

Downloads

Download data is not yet available.

References

Alanazi, A. S., Alfadl, A. A. & Hussain, A.S. (2016). Pharmaceutical care in the community pharmacies of Saudi Arabia: present status and possibilities for improvement, Saudi J Med Med Sci, 4, 9–14. DOI 10.4103/1658-631X.170881.

Alen, L. V., Popovich, N.G. & Ansel, H.C. (2011). Ansel's pharmaceutical dosage forms and drug delivery systems. Baltimore: Lippincott wi liams & wilkins.

Alrasheedy, A. A. (2024). Pharmaceutical Activities, Services, Medicines, and Products at Community Pharmacies in the Qassim Region of Saudi Arabia: Findings and Implications for the Future, Cureus, 16 (8), e67957. DOI 10.7759/cureus.67957.

Bel, J.S., Vaananen, M., Ovaskainen, H., Narhi, U. & Airaksinen, M. S. (2007). Providing patient care in community pharmacies: practice and research in Finland, Ann Pharmacother; 41 (6), 1039–1046. DOI: 10.1345/aph.1H638.

Cucić, V., Simić, S., Bjegović, V., Živković, M., Doknić Stefanović, D. & Vuković, D. (2000). Socijalna medicina [Social medicine]. Beograd: Savremena administracija.

Đekić, Lj., Čalija, B. & Vuleta, G. (2013). Izrada magistralnih i galenskih lekova – propisi i standardi [Production of magisterial and galenic medicines - regulations and standards], Arhiv za farmaciju, 63 (5), 443–469.

Evans, D. B., Tandon, A., Murray, C. J. & Lauer, J. A. (2001). Comparative e ficiency of national health systems: cross national econometric analysis. BMJ, 323 (11), 307–310. DOI: 10.1136/bmj.323.7308.307.

Farmaceutska komora Srbije [Pharmaceutical Chamber of Serbia] (2021). Vodič dobre apotekarske prakse [Guide to good pharmacy practice]. Beograd. https://www.farmkom.rs/pdf/stranice/Vodi%C4%8D%20DAP.pdf

Herborg, H., Sorensen, E. w. & Frokjaer, B. (2007) Pharmaceutical care in community pharmacies: practice and research in Denmark, Ann Pharmacother, 41 (4), 681-689. DOI: 10.1345/aph.1H645.

Janković, D. (2011). Zdravstveno osiguranje kao faktor troškova zdravstvene zaštite [Health insurance as a factor in health care costs], Škola biznisa, 4, 69–82.

Jovanović, S., Milovanović, S., Mandić, J. & Jovović, S. (2015). Sistemi zdravstvene zaštite [Health care systems]. Engrami, 37 (1), 75-82.

Jovanović, Ž. (2016). Upravljanje strateškim promenama u farmaceutskoj industriji (Doktorska disertacija, Fakultet organizacionih nauka, Univerzitet u Beogradu) [Strategic Change Management in Pharmaceutical Industry, Faculty of Organizational Sciences, University of Belgrade]. Beograd. https://nardus.mpn.gov.rs/bitstream/handle/123456789/6876/Disertacija.pdf

Jović, S. & Tasić, Lj. (2009). Dobra apotekarska praksa – značaj i uloga u farmaceutskoj delatnosti Srbije [Good pharmacy practice - importance and role in the pharmaceutical industry of Serbia], Arhiv za farmaciju, 59 (1), 1–12.

Kočović, J., Rakonjac-Antić, T. & Rajić, V. (2013). Dobrovoljno zdravstveno osiguranje kao dopuna obaveznom zdravstvenom osiguranju u Srbiji [Voluntary health insurance as a supplement to mandatory health insurance in Serbia]. Ekonomske teme, 51 (3), 541–560.

Kosanović, R. (2011). Socijalno pravo [Social law]. Beograd: Friedrich Ebert Stiftung.

Kosanović, R. & Anđelski, H. (2015). Osnovni pravci razvoja zdravstvenog osiguranja u Republici Srbiji (1922−2014) [Basic trends in the development of health insurance in the Republic of Serbia (1922−2014)]. Zdravstvena zaštita, 44 (3), 48–70.

Ministarstvo zdravlja [Ministry of Health] (2011). Pravilnik o načinu kontrole kvaliteta lekova i medicinskih sredstava [Rulebook on the method of quality control of medicines and medical devices], Službeni glasnik RS, br. 64/2011, 63/2013, 99/2018 - dr. pravilnik, 93/2022, 102/2022, 87/2023 i 63/2024. https://www.paragraf.rs/propisi/pravilnik-o-nacinu-kontrole-kvaliteta-i-lekova-i-medicinskihsredstava.html

Ministarstvo zdravlja [Ministry of Health] (2022). Pravilnik o kliničkom ispitivanju lekova u humanoj medicine [Rulebook on clinical testing of drugs in human medicine], Službeni glasnik RS, br. 51/2022, 65/2023, 86/2023 i 97/2024. https://pravno-informacioni-sistem.rs/eli/rep/sgrs/ministarstva/pravilnik/2024/97/5

Ministarstvo zdravlja [Ministry of Health] (2025). Smernice dobre kliničke prakse [Good clinical practice guidelines], Službeni glasnik RS, br. 65/2025. https://pravno-informacioni- sistem.rs/eli/rep/sgrs/ministarstva/drugiakt/2025/65/1/reg

Ministarstvo zdravlja [Ministry of Health] (2011). Pravilnik o načinu prijavljivanja, prikupljanja i praćenja neželjenih reakcija na lekove [Rulebook on how to report, co lect and monitor adverse drug reactions], Službeni glasnik RS, br. 64/2011, 75/2017, 82/2017 – ispr. i 107/2023. https://www.paragraf.rs/propisi/pravilnik-o-nacinu-prijavljivanja-prikupljanja-i-pracenja-nezeljenihreakcija-na-lekove.html

Ministarstvo zdravlja [Ministry of Health] (2018). Pravilnik o obrascu i sadržini lekarskog recepta, načinu izdavanja i propisivanja lekova [Rulebook on the form and content of a doctor's prescription, the method of issuing and prescribing medicines], Službeni glasnik RS, br. 74/2018, 87/2018, 47/2019, 90/2019, 150/2020, 127/2021, 134/2022, 143/2022, 2/2023, 115/2023, 24/2024, 55/2024, 101/2024 i 105/2025. https://pravno-informacioni-sistem.rs/eli/rep/sgrs/ministarstva/pravilnik/2018/74/2/reg

Ministarstvo zdravlja [Ministry of Health] (2010). Pravilnik o načinu oglašavanja leka, odnosno medicinskog sredstva [Rulebook on the method of advertising a medicine, that is, a medical device], Službeni glasnik RS, br. 79/2010 i 102/2018 – dr. pravilnik. https://www.paragraf.rs/propisi/pravilnik_o_nacinu_oglasavanja_leka_odnosno_medicinskog_sredstva.html

Mitrović, M. & Gavrilović, A. (2013). Organizacija i menadžment u zdravstvenom sistemu Srbije [Organization and management in the healthcare system of Serbia]. FBIM Transactions, 1 (2), 145–158.

Mohammed, E., Khanal, S., Jalal, Z., Cheema, E., Abutaleb, M. H. &, Paudyal, V. (2021). Perceived barriers and facilitators to uptake of non-traditional roles by pharmacists in Saudi Arabia and implications for COVID-19 pandemic and beyond: a qualitative study using Theoretical Domain Framework, J Pharm Policy Pract, 14 (1), 25. DOI: 10.1186/s40545-021-00307-w.

Mujović Zornić, H. (2008). Farmaceutsko pravo [Pharmaceutical law], Beograd: Nomos.

Narodna skupština Republike Srbije [National Assembly of the Republic of Serbia] (2010). Zakon o lekovima i medicinskim sredstvima [Law on Medicines and Medical Devices], Službeni glasnik RS, br. 30/2010, 107/2012, 113/2017 – dr. zakon i 105/2017 – dr. zakon. https://www.paragraf.rs/propisi/zakon_o_lekovima_i_medicinskim_sredstvima.html

Narodna skupština Republike Srbije [National Assembly of the Republic of Serbia] (2017). Zakon o medicinskim sredstvima [Law on medical devices], Službeni glasnik RS, br. 1052017. https://www.paragraf.rs/propisi/zakon-o-medicinskim-sredstvima.html

Narodna skupština Republike Srbije [National Assembly of the Republic of Serbia] (2006). Ustav Republike Srbije [Constitution of the Republic of Serbia], Službeni glasnik RS, br. 98/2006 i 115/2021. https://www.paragraf.rs/propisi/ustav_republike_srbije.html

Narodna skupština Republike Srbije [National Assembly of the Republic of Serbia] (2019). Zakon o zdravstvenoj zaštiti [Health Care Law]. Službeni glasnik RS, br. 25/2019, 92/2023 – autentično tumačenje i 29/2025 – odluka US. https://www.paragraf.rs/propisi/zakon_o_zdravstvenoj_zastiti.html

Narodna skupština Republike Srbije [National Assembly of the Republic of Serbia] (2019). Zakon o zdravstvenom osiguranju [Law on Health Insurance]. Službeni glasnik RS, br. 25/2019, 92/2023 i 109/2025 – dr. zakon. https://www.paragraf.rs/propisi/zakon_o_zdravstvenom_osiguranju.html

Noyce, P. R. (2007). Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother. 41 (5), 861-868. DOI: 10.1345/aph.1K015.

Radivojević, V. & Vesić, S. (2020). Neki aspekti razvoja zdravstvenog sistema Srbije i Japana [Some aspects of the development of the healthcare system in Serbia and Japan]. Naučne publikacije Državnog univerziteta u Novom Pazaru – Serija B: Društvene & humanističke nauke, 3 (2), 152–165.

Remington, J. P. (2012). The Science and Practice of Pharmacy, London: Pharmaceutical Press.

Republički fond za zdravstveno osiguranje [Republic Fund for Health Insurance] (2025). Pravilnik o listi lekova koji se propisuju i izdaju na teret sredstava obaveznog zdravstvenog osiguranja [Rulebook on the list of medicines that are prescribed and issued at the expense of compulsory health insurance funds], Službeni glasnik RS, br. 50/2025, 91/2025 i 13/2026. https://www.paragraf.rs/propisi/pravilnik_o_listi_lekova_koji_se_propisuju_i_izdaju_na_teret_sredstava_obaveznog_zdravstvenog_osiguranja.html

Rossing, C., Hansen, E. H., Traulsen, J. M. & Krass, I. (2005). Actual and perceived provision of pharmaceutical care in Danish community pharmacies: the pharmacists' opinions, Pharm World Sci, 27 (3), 175-181. DOI: 10.1007/s11096-004-1732-3.

Simic, S. (2012). Zdravstveni sistemi [Health systems]. Beograd: Medicinski fakultet, Centar – Škola javnog zdravlja.

Tasić, Lj., Hadži-Arsić Novaković, S. (2005). Znanjem do kvaliteta u farmaceutskom poslovanju [From knowledge to quality in pharmaceutical business], Total quality management & exce lence, 33 (12), 225-227.

Vrcelj Jovanović, S., Vukajlović, I. & Stajković, Z. (2022). Nacionalni registar lekova [National Medicines Registry]. Beograd: Agencija za lekove i medicinska sredstva Srbije.

Westerlund, L.T. & Bjork, H.T. (2006). Pharmaceutical care in community pharmacies: practice and research in Sweden, Ann Pharmacother, 40 (6), 1162-1169. DOI: 10.1345/aph.1G680.